Viral Clearance Studies – Current and Future Expectations

When:  Tue, Oct 20, 2026 from 02:30 PM to 03:30 PM (SG)
Associated with  National Space

Tailored specifically for our Asia-Pacific audience, this session offers a first-of-its-kind discussion on the current landscape and future expectations of viral clearance. The session will feature Dr. Horst Ruppach, expert in viral safety and viral clearance with over 25 years of experience in virology.

Webinar Details:

  • Date: 20 October 2026
  • Time: 14:30 – 15:30 (SGT / UTC+8)
  • Format: Zoom Live Webinar
  • Registration: Register Now

Why Attend:

This webinar will address past, current, and future viral clearance study designs. The discussion will be illustrated for classical CHO-derived recombinants as well as for more advanced products like Adeno-Associated Viral Vector products.

Key Topics Include:

  • ICH Q5A(R2)
  • Reduced study designs
  • Regulatory acceptance
  • Viral vector product types and others (e.g. vaccines)
  • Platform approaches
  • Prior knowledge
  • New technologies (e.g. multi-spiking)
Event Image

Contact

Tara Cassidy

tara.cassidy@crl.com

Location